Balchem Corporation
General ticker "BCPC" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $5.3B (TTM average)
Balchem Corporation does not follow the US Stock Market performance with the rate: -0.3%.
Estimated limits based on current volatility of 1.0%: low 153.65$, high 156.65$
Factors to consider:
- Company pays dividends (annually): last record date 2024-12-26, amount 0.87$ (Y0.57%)
- Total employees count: 1361 as of 2024
- US accounted for 75.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Cybersecurity threats, Currency fluctuations, Interest rate fluctuations, Acquisition/divestiture risks
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [143.17$, 193.52$]
- 2025-12-31 to 2026-12-31 estimated range: [149.44$, 201.98$]
Financial Metrics affecting the BCPC estimates:
- Negative: with PPE of 38.7 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 19.18 > 18.64
- Positive: 0 < Industry earnings per price (median), % of 2.23
- Positive: Shareholder equity ratio, % of 72.99 > 63.39
- Positive: 2.97 < Industry operating profit margin (median), % of 6.49
- Positive: 0.33 < Operating cash flow per share per price, % of 3.40
- Positive: Interest expense per share per price, % of 0.31 <= 0.79
- Positive: Industry inventory ratio change (median), % of -0.31 <= -0.15
Short-term BCPC quotes
Long-term BCPC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $942.36MM | $922.44MM | $953.68MM |
| Operating Expenses | $797.17MM | $763.25MM | $770.77MM |
| Operating Income | $145.19MM | $159.19MM | $182.91MM |
| Non-Operating Income | $-11.44MM | $-21.93MM | $-16.46MM |
| Interest Expense | $10.27MM | $22.61MM | $16.53MM |
| R&D Expense | $12.19MM | $15.05MM | $16.79MM |
| Income(Loss) | $133.75MM | $137.26MM | $166.45MM |
| Taxes | $28.38MM | $28.72MM | $37.98MM |
| Profit(Loss)* | $105.37MM | $108.54MM | $128.47MM |
| Stockholders Equity | $938.28MM | $1,053.98MM | $1,149.91MM |
| Inventory | $119.67MM | $109.52MM | $130.80MM |
| Assets | $1,624.51MM | $1,597.21MM | $1,575.37MM |
| Operating Cash Flow | $138.54MM | $183.76MM | $182.00MM |
| Capital expenditure | $50.29MM | $37.89MM | $35.66MM |
| Investing Cash Flow | $-416.01MM | $-34.81MM | $-59.74MM |
| Financing Cash Flow | $246.68MM | $-153.32MM | $-133.81MM |
| Earnings Per Share** | $3.29 | $3.38 | $3.97 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.